(Date:11/24/2009)... , Health Care Reform cre...mdash;such as managing chronic care treatment&mdas...t. , Alpharetta, GA (Vocu...oncerning health care reform is controversial, to ...surers, legislators and policy makers all weighing...
(Date:11/24/2009)... , Slate and New Markets ...he business services sector. , ...Slate Capital Group ( www.slatecap.com ), a privat...w Markets Venture Partners ( www.newmarketsvp.com ...aryland, today announced that they have acquired E...
(Date:11/24/2009)... , Two expert therapists ...ink readers. a - ban,- don: verb: to leave comple... Vancouver, Canada (Vocus) N...role Gaato today announced the second webinar is i...Century Therapy" series from MyShrink.com ( h...
(Date:11/24/2009)... , Sinusitis patients lif...nic sinusitis, Sinus Dynamics non-invasive nasal s...venience of treating all types of Sinusitis withou...ny sinus surgery. Researchers found 82.9% of patie...ized antibiotics with mean particle diameter of 3....
(Date:11/24/2009)... , NCL Security Launches ...Industry to Generate Recurring Monthly Revenue for... Dallas, Texas (PRWEB) November 24...Video Platform for the Security Industry to Genera...and Security Dealers., , ,"Integrated securit...
Breaking Medicine News(10 mins):Health News:Jackson & Coker Industry Report Addresses Health Care Reform 2Health News:Jackson & Coker Industry Report Addresses Health Care Reform 3Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 2Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 3Health News:Home For the Holidays: MyShrink.com Announces the Second in its Successful Six-Part Webinar Series: "Abandonment: The Hidden Fear" 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 4Health News:NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Dealers 2...3.9 Million; 29% Increase .... Sales of $2.2 Million; 83% Increase ...linical Study Launched to Expand Reimbursement, Su...c. (Amex:,UPI), a medical device company that deve...
...rs, Joe Torre; and Cedars-Sinai, Medical Center, ... Wyman Humanitarian Award at Awards Gala on We... Southern California,Chapter of the Arthritis Foun...lls hotel. The highlight of the evening will,be th...
...o save $7 billion in related health-care costs , ...ccinating infants with what,s known as the "7 vale...ve more than 357,000 lives and $7 billion in costs...h as meningitis) and other bacterial infections ca...
... Recognizing the nationwide critical need for tech... by accurately tracking their location inside buil...rded Worcester Polytechnic Institute (WPI) $430,00...go. It was also announced that, with this funding,...
...re,s Global Promise, DALLAS, Oct. 29 Susan G. Ko...st cancer movement, is expanding its international...vice president of,international, reporting to Kome...t, implementation and management of,Komen,s growin...
...hoose Regence,s,Health Savings Account (HSA) will ...e company has added U.S. Bank as a banking partner... approach to health care banking,and its strong co...evel of quality and,financial services they have c...
Other Medicine News:Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 2Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 3Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 4Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 5Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 6Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 7Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 8Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 9Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 10Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 11Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 12Health News:Arthritis Foundation Honors Comerica Bank at 'Commitment To A Cure' Awards Gala 2Health News:Arthritis Foundation Honors Comerica Bank at 'Commitment To A Cure' Awards Gala 3Health News:Arthritis Foundation Honors Comerica Bank at 'Commitment To A Cure' Awards Gala 4Health News:Flu Vaccine Could Prevent 357,000 Deaths in Pandemic 2Health News:WPI receives award from Homeland Security Department to advance first-responder location 2Health News:WPI receives award from Homeland Security Department to advance first-responder location 3Health News:WPI receives award from Homeland Security Department to advance first-responder location 4Health News:Susan G. Komen for the Cure(R) Strengthens Global Mission With Addition of Vice President, International 2Health News:Susan G. Komen for the Cure(R) Strengthens Global Mission With Addition of Vice President, International 3Health News:Regence Teams With U.S. Bank to Offer New Health Savings Account Solution 2(Date:11/23/2009).../--LightSciencesOncology,Inc.(LSO)todayannouncedth...toanewlycreatedseatonitsboardofdirectors.Mr.Seddig...panies,includingElekta,tomarketleadership. ,, "...thinbusinessdevelopmenttotheboard,"saidLSO,sChairm...ncancer-therapybusinessdevelopment.Hehasoverseenth...
(Date:11/23/2009)...e-FirstCall/-- CumberlandPharmaceuticalsInc. (CPIX...studyevaluatingthesafetyandefficacyofCaldolor( ibu...patients. ,, Statisticalsignificancewasachieved...overthefirst24hoursoftreatment.Thestudyevaluated61...ingmorethan10percenttotalbodysurfacearea.Otherpart...
(Date:11/23/2009)...e-FirstCall/--WoundManagementTechnologies,Inc.,(OT...altymedicalproducts,announcedthatithasfileditQ3200...ementbusinessupdatetoillustratethedevelopmentsduri...33.5%to$102,926vs.Q32008salesof$77,084. , Sha....Q32008shareholderequityof$(321,257) , Totala...
Breaking Medicine Technology:Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 1Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 2Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 3Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 4Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material 5315 1Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material 5315 2Survivors of childhood cancer less likely to marry 10291 1Survivors of childhood cancer less likely to marry 10291 2...Data to the NEBIDO NDA PDUFA Date Exp...Jan. 22 Indevus,Pharmaceuticals, Inc. (Nasdaq: I...from its Phase III program for NEBIDO (testosteron...one therapy under development for the,treatment of... has been,filed with the U.S. Food and Drug Admini...
...te Anti-Tumor Activity of Bavituximab in ... TUSTIN, Calif., Jan. 22 Peregrine,Pharmaceutical...maceutical,company developing monoclonal antibodie...s (HCV) infection, today announced that its Phase ...nation with chemotherapy in,patients with non-smal...
Other Medicine Technology:Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 2Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 3Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 4Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 5Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 6Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4The Natural-Hip Family - Revision/Trauma Nonporous CoCr
MARATHON Cross Linked Polyethylene Acetabular Liner
Ringloc Acetabular Liners
Olympia Total Shoulder System
Medicine Products: